or Try an Advanced Search...

    Technical Analysis for GNLX - Genelux Corporation

    Grade Last Price % Change Price Change
    C 3.21 -0.31% -0.01
    GNLX closed down 0.31 percent on Friday, November 1, 2024, on 37 percent of normal volume.
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Up Up
    Historical GNLX trend table...
    Date Alert Name Type % Chg
    Upper Bollinger Band Walk Strength 0.00%
    Wide Bands Range Expansion 0.00%
    Gapped Up Strength 0.00%
    Upper Bollinger Band Touch Strength 0.00%
    Upper Bollinger Band Walk Strength -0.31%
    Wide Bands Range Expansion -0.31%
    Upper Bollinger Band Touch Strength -0.31%
    Wide Bands Range Expansion -3.60%
    Above Upper BB Strength -3.60%
    Up 3 Days in a Row Strength -3.60%
    Older End-of-Day Signals for GNLX ...

       Recent Intraday Alerts

    Alert Time
    Down 3% about 19 hours ago
    60 Minute Opening Range Breakdown about 23 hours ago
    Down 2 % about 23 hours ago
    Gap Up Closed about 23 hours ago
    Down 1% about 23 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    GNLX Chart by TradingView
    Basic chart:

    Profile

    Genelux Corporation, a clinical-stage biopharmaceutical company, focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive and/or difficult-to-treat solid tumor types. Its lead product candidate is Olvi-Vec, a proprietary, modified strain of the vaccinia virus for the treatment of ovarian cancer and non-small-cell lung cancer. The company is also developing V2ACT Immunotherapy for the treatment of pancreatic cancer; and V-VET1 to treat hematologic and solid cancer. The company was incorporated in 2001 and is headquartered in Westlake Village, California.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Biopharmaceutical Cancer Clinical Medicine Immunotherapy Immunotherapies Virotherapy Non Small Cell Lung Cancer Ovarian Cancer Pancreatic Cancer Oncolytic Virus Experimental Cancer Treatments Transgene Sa Treatment Of Ovarian Cancer Treatment Of Pancreatic Cancer

    Is GNLX a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 2 bullish, 1 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Oct 31 Genelux: H2 2025 PRROC Data Is A Major Inflection Point
    Oct 31 Individual investors who hold 56% of Genelux Corporation (NASDAQ:GNLX) gained 34%, institutions profited as well
    Oct 29 Genelux started at buy by Guggenheim ahead of Olvi-vec data
    Oct 25 Highbridge Capital Management LLC Acquires Significant Stake in Genelux Corp
    Oct 23 Genelux doses first subject in Phase II trial of NSCLC treatment
    Oct 22 Genelux Corporation Announces First Patient Dosed in Phase 2 Trial Evaluating Systemic Therapy with Olvi-Vec in Non-Small Cell Lung Cancer
    Oct 9 Genelux Corporation to Participate in the 2024 Maxim Healthcare Virtual Summit
    Sep 3 Genelux Corporation to Present at the H.C. Wainwright Global Investment Conference
    Aug 29 Genelux started at buy by Roth MKM ahead of Olvi-Vec readouts
    Aug 17 Is Genelux (NASDAQ:GNLX) In A Good Position To Invest In Growth?
    See more GNLX news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 17.48
    52 Week Low 1.6
    Average Volume 172,707
    200-Day Moving Average 4.06
    50-Day Moving Average 2.52
    20-Day Moving Average 2.80
    10-Day Moving Average 2.86
    Average True Range 0.28
    RSI (14) 64.54
    ADX 36.93
    +DI 36.87
    -DI 9.94
    Chandelier Exit (Long, 3 ATRs) 2.77
    Chandelier Exit (Short, 3 ATRs) 3.15
    Upper Bollinger Bands 3.36
    Lower Bollinger Band 2.24
    Percent B (%b) 0.87
    BandWidth 39.76
    MACD Line 0.19
    MACD Signal Line 0.13
    MACD Histogram 0.0509
    Fundamentals Value
    Market Cap 85.76 Million
    Num Shares 26.7 Million
    EPS -1.06
    Price-to-Earnings (P/E) Ratio -3.03
    Price-to-Sales 1003.60
    Price-to-Book 10.42
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 3.80
    Resistance 3 (R3) 3.83 3.66 3.70
    Resistance 2 (R2) 3.66 3.51 3.65 3.66
    Resistance 1 (R1) 3.44 3.42 3.36 3.41 3.63
    Pivot Point 3.27 3.27 3.23 3.26 3.27
    Support 1 (S1) 3.05 3.12 2.97 3.02 2.79
    Support 2 (S2) 2.88 3.03 2.87 2.76
    Support 3 (S3) 2.66 2.88 2.72
    Support 4 (S4) 2.63